ArticleThe Journal of clinical investigation2005

Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.

Kazunori Nagashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.